共 6 条
- [4] Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (02)